title: Treatment with activated protein C immediately after cardiac surgery.
authors.affiliation: Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA. jana.hudcova@lahey.org
authors.forename: Jana
authors.initials: J
authors.lastname: Hudcova
authors.forename: Todd
authors.initials: T
authors.lastname: Sarge
authors.forename: Alan
authors.initials: A
authors.lastname: Lisbon
authors.forename: Sugantha
authors.initials: S
authors.lastname: Sundar
authors.forename: Daniel
authors.initials: D
authors.lastname: Talmor
mesh_terms: D000038:Abscess / Q000188:drug therapy*; D000328:Adult; D000925:Anticoagulants; D006349:Heart Valve Diseases / Q000188:drug therapy*; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D011486:Protein C / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012772:Shock, Septic / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D011486:Protein C; D011994:Recombinant Proteins